Xiaohan Qian

State Key Laboratory For Diagnosis And Treatment Of Infectious Diseases
Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Immune checkpoint TIM-3 defines hyperactivated NK cells and predicts fatal outcome in severe fever with thrombocytopenia syndrome.

Immune checkpoint TIM-3 defines hyperactivated NK cells and predicts fatal outcome in severe fever with thrombocytopenia syndrome.

Journal: PLoS neglected tropical diseases

Published: July 14, 2025

Lesser-known non-apoptotic programmed cell death in viral infections.

Lesser-known non-apoptotic programmed cell death in viral infections.

Journal: Virus research

Published: June 10, 2025

Single-cell analysis identifies RETN+ monocyte-derived Resistin as a therapeutic target in hepatitis B virus-related acute-on-chronic liver failure.

Single-cell analysis identifies RETN+ monocyte-derived Resistin as a therapeutic target in hepatitis B virus-related acute-on-chronic liver failure.

Journal: Gut

Published: May 29, 2025

Clinical, Microbiological, and Antibiotic Treatment Characteristics of Bacterial Infections in Patients with Liver Cirrhosis in China: A Multicenter Study.

Clinical, Microbiological, and Antibiotic Treatment Characteristics of Bacterial Infections in Patients with Liver Cirrhosis in China: A Multicenter Study.

Journal: Journal of clinical and translational hepatology

Published: May 07, 2025

Validation of the CLIF-SIG score in patients with HBV-related acutely decompensated cirrhosis.

Validation of the CLIF-SIG score in patients with HBV-related acutely decompensated cirrhosis.

Journal: Gut

Published: May 06, 2025

The Association Between Thromboembolic Events and ALK, ROS1, RET Rearrangements or EGFR Mutations in Patients With Advanced Lung Adenocarcinoma: A Retrospective Cohort Study.

The Association Between Thromboembolic Events and ALK, ROS1, RET Rearrangements or EGFR Mutations in Patients With Advanced Lung Adenocarcinoma: A Retrospective Cohort Study.

Journal: Thoracic cancer

Published: April 25, 2025

Correction: Longitudinal dynamic single-cell mass cytometry analysis of peripheral blood mononuclear cells in COVID-19 patients within 6 months after viral RNA clearance.

Correction: Longitudinal dynamic single-cell mass cytometry analysis of peripheral blood mononuclear cells in COVID-19 patients within 6 months after viral RNA clearance.

Journal: BMC infectious diseases

Published: September 26, 2024

Longitudinal dynamic single-cell mass cytometry analysis of peripheral blood mononuclear cells in COVID-19 patients within 6 months after viral RNA clearance.

Longitudinal dynamic single-cell mass cytometry analysis of peripheral blood mononuclear cells in COVID-19 patients within 6 months after viral RNA clearance.

Journal: BMC infectious diseases

Published: September 09, 2023

The 90-Day Survival Threshold: A Pivotal Determinant of Long-Term Prognosis in HBV-ACLF Patients - Insights from a Prospective Longitudinal Cohort Study.

The 90-Day Survival Threshold: A Pivotal Determinant of Long-Term Prognosis in HBV-ACLF Patients - Insights from a Prospective Longitudinal Cohort Study.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 30, 2023

Driver Genes Associated With the Incidence of Venous Thromboembolism in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Driver Genes Associated With the Incidence of Venous Thromboembolism in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Journal: Frontiers in oncology

Published: March 13, 2021

Sec3 knockdown inhibits TGF-β induced epithelial-mesenchymal transition through the down-regulation of Akt phosphorylation in A549 cells.

Sec3 knockdown inhibits TGF-β induced epithelial-mesenchymal transition through the down-regulation of Akt phosphorylation in A549 cells.

Journal: Biochemical and biophysical research communications

Published: August 06, 2019

Phospholipase D as a key modulator of cancer progression.

Phospholipase D as a key modulator of cancer progression.

Journal: Biological reviews of the Cambridge Philosophical Society

Published: June 21, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026